Sanofi, Merck Vaccine To Bolster Vaccination Rates Across US – DPI Research | Market Research Reports | Market Reports Available

Get In Touch

Sanofi, Merck Vaccine To Bolster Vaccination Rates Across US

The US Food and Drug Administration (FDA) recently approved pharma giants Sanofi and Merck’s Vaxelis, a new pediatric vaccine against six diseases. The vaccine will help to bolster vaccination rates across the US by reducing the shot burden on infants and children, according to GlobalData, a leading data and analytics company.

Vaxelis, which is indicated for active immunization to prevent diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and invasive disease due to Haemophilus influenzae type b, was developed as part of a joint-partnership between Sanofi and Merck, known as MSD outside the US and Canada.

James Mather, Pharma Analyst at GlobalData, says: “Vaxelis’ approval in the US is a major regulatory breakthrough, as the FDA has been more hesitant than the European Medicines Agency (EMA), which approved Vaxelis in 2015, in the acceptance of high-valiancy diphtheria, tetanus, and acellular pertussis (DTaP) vaccines.”

Unlike its rival six-in-one vaccine in Europe, GlaxoSmithKline’s (GSK’s) Infanrix Hexa (DTaP-IPV-HepB/Hib), Vaxelis is fully liquid and therefore does not require reconstitution, providing a more convenient route of administration for physicians and their office staff.

Source: https://www.biospectrumasia.com/news/30/12562/sanofi-merck-vaccine-to-bolster-vaccination-rates-across-us.html

Visit For More Reports on Vaccines: https://dpiresearch.com/

Related Post
United States Vaccines Market is set to Experience a Revolutionary growth by 2025 – DPIResearch.com

United States pediatric vaccines market is expected to grow over US$ 15 Billion by 2025, driven by increased disease awareness, Read more

United States Pneumococcal & Meningococcal Vaccines Market Insights By Top Players – DPIResearch.com

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of Read more

United States Flu Vaccines Market Development Forecast 2020-2025 – DPIResearch.com

The United States influenza vaccines market size is anticipated to observe tremendous growth projections during 2019 – 2025. https://www.youtube.com/watch?v=zQwc3jE2eQc

Global Human Vaccines Market: Strong Sales Outlook Ahead

The global market size for human vaccines is anticipated to observe tremendous growth projections during 2019 – 2025. https://www.youtube.com/watch?v=iXTmbZBl5VM

Spread the love
X
Open chat